B-MoGen, CytoSen to develop NK cell therapies

B-MoGen Biotechnologies Inc. (Minneapolis, Minn.) and CytoSen Therapeutics Inc. (Orlando, Fla.) partnered to develop gene-modified NK cell therapies. B-MoGen will use its non-viral gene delivery pla...